Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma

Prasad’s stricter FDA policy for COVID-19 vaccines could limit future access

FDA—under the leadership of cyber-iconoclast and new director of the agency’s Center for Biologics Evaluation and Research, Vinay Prasad—is taking a new approach to COVID-19 vaccines.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

Funding Opportunities

DOD melanoma research program FY25 funding opportunities

The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650M in funding for the CDMRP.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Gene-based blood test for melanoma may detect early signs of cancer return

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a recent study led by researchers at NYU Langone Health and its Perlmutter Cancer Center shows.

April 18, 2025

Vol.51 No.15

Drugs & Targets

FDA approves Keytruda combination for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)

FDA granted traditional approval to Merck’s pembrolizumab (Keytruda) with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma whose tumors express PD-L1 (CPS ≥1).

March 21, 2025

Vol.51 No.11

Capitol Hill

Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs

Amid the flood zone of today’s Washington, the confirmation hearing for Jayanta (Jay) Bhattacharya’s nomination as director of NIH was remarkably calm.

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Each year, nearly 14 million people in the U.S. contract human papillomavirus, a common, sexually-transmitted virus that can cause several cancers.

March 07, 2025

Vol.51 No.09

By Claire Marie Porter

Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma

YOU MAY BE INTERESTED IN

Prasad’s stricter FDA policy for COVID-19 vaccines could limit future access

DOD melanoma research program FY25 funding opportunities

Gene-based blood test for melanoma may detect early signs of cancer return

FDA approves Keytruda combination for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)

Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Renew today!

Subscriber content

Never miss an issue!

Login

Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma

YOU MAY BE INTERESTED IN

Prasad’s stricter FDA policy for COVID-19 vaccines could limit future access

DOD melanoma research program FY25 funding opportunities

Gene-based blood test for melanoma may detect early signs of cancer return

FDA approves Keytruda combination for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)

Bhattacharya provides calm answers to anxious questions at confirmation hearingTrump nominee for NIH director calls for transparency, audits of indirect costs

Survey reveals most Americans are uninformed about HPVA vaccine can prevent cancer—most people don’t take it

Never miss an issue!

Login

FDA approves Keytruda combination for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)

Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it